Moderna beats top-line and bottom-line estimates; updates FY25 outlook

4 days ago 1

Earnings News

Comments

Moderna press release (NASDAQ:MRNA): Q2 GAAP EPS of -$2.13 beats by $0.84.
Revenue of $142M (-41.1% Y/Y) beats by $29.44M.
Cash, cash equivalents and investments as of June 30, 2025, were $7.5 billion, compared to $8.4 billion as of March 31, 2025. The decrease during the quarter was

Recommended For You

More Trending News

Read Entire Article